Arthneeti

India Glycols Q1 FY27 Share Price & Earnings Call Analysis

₹331.70+0.42% today
Market cap
₹2,223 Cr
P/E
7.03
ROE
11.26%
PEG
0.19
Price to sales
0.53
Debt to equity
0.58
52W high / low
₹1,203 / ₹236
Sales growth (5Y)
12.69%
EBITDA margin
15.56%
Net profit margin
6.94%
Promoter holding
59.63%
Sales (last year)
₹4,301 Cr

Established in 1988, India Glycols Ltd. is engaged in the manufacturing of green technology-based bulk, specialty & performance chemicals, and natural gums, spirits, industrial gases, sugar, and nutraceuticals. [1][2]

Guidance scorecard · Q1 FY27 call

What India Glycols's management guided
and where it ranks in Beverages

Revenue10–20%MarginsFlatCapexPlannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

10–20%
  • Potable Spirits segment expects revenue growth to exceed volume growth due to premiumization and new high-margin offerings in deluxe whisky, semi-premium vodka, and white spirits.
  • IMFL revenue expected to be over 30% of Potable Spirit revenue in FY27.
  • Doubling of potable spirits volume planned for FY27 with deeper state penetration and new brand launches.
  • Spirits business targeting EBITDA over INR 500 crores in FY27, aiming for INR 1,000 crores in 4-5 years.
  • Chemicals business shows 25% YoY revenue growth; pipeline strong in performance chemicals.
  • ENNature Bio Pharma targeting INR 130-150 crores EBITDA over next 4-5 years with growth in nicotine and nutraceuticals.
  • Business restructuring to enhance focus and investor clarity, aiding growth.

2 more points from India Glycols's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what India Glycols said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • For the NSU (Nutraceuticals and Specialty Uses) segment, incremental capex of approximately INR 5-20 crores is planned for the current year.
  • No major large-scale capex (like INR 400-500 crores plant) is expected in the next 2 years unless new technologies are pursued.
  • Modular expansion approach will be followed as business grows.
  • The core plant expansion till now involved around INR 50-60 crores investment, utilizing some existing assets.
  • Investment plans include scaling up capacity, new product introductions, and customer engagement to grow NSU business.

2 more points from India Glycols's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what India Glycols said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • Ennature Bio Pharma has a strong order pipeline supporting 26% growth in Thiocolchicoside sales.
  • The Spirits business is targeting healthy double-digit volume growth driven by new offerings and deeper penetration.
  • The joint venture performance is steady, with increased sales and exports to Clariant customers worldwide.

2 more points from India Glycols's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis
Full Beverages ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Beverages
on management's own guidance

  1. Varun BeveragesGood growth
    2
  2. Strong growth
    1
  3. FratelliVineyardGood growth
    3
See all potential multibaggersWhere does India Glycols rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Beverages companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Flat₹5,815 Cr41.4
2Varun Beverages20–40%Flat₹1.46L Cr43.0
3FratelliVineyard20–40%Flat₹537 Cr—
410–20%Up 2%+₹19,866 Cr89.0
510–20%Up 2%+₹13,672 Cr60.5
610–20%Flat₹31,771 Cr91.9

Sign up free to see every company in the sector ranking and track India Glycols.

Pro shows every company guiding 40%+ revenue growth →Full Beverages ranking

India Glycols announcements

All announcements →

Financials of India Glycols

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of India Glycols

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6196897759049269699619758631,0401,0921,102976
Expenses +523589679802822843845852717891935927810
Operating Profit9610096102105126116124146150158175166
OPM %16%15%12%11%11%13%12%13%17%14%14%16%17%
Other Income +61212910141519132014314
Interest26282931333640444545494726
Depreciation30212826262828273334384141
Profit before tax466450545676637182918491112
Tax %13%20%24%23%24%20%22%20%22%19%22%25%23%
Net Profit +40513842426050576473656887
EPS in Rs6.518.266.146.736.829.758.039.1810.3411.8310.5110.0812.96

Financials of India Glycols

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2,5792,3242,5003,0343,3572,7352,3172,8682,6513,2943,7684,211
Expenses +2,4552,1492,2632,7122,9412,4332,0262,5992,3462,8793,2473,562
Operating Profit124175237322416303291269305415521649
OPM %5%8%9%11%12%11%13%9%12%13%14%15%
Other Income +-16-4772317241526054305151
Interest163139127125143978370100121164167
Depreciation896972737678808094101115155
Profit before tax-144-8145147213153143379165223292377
Tax %-38%-30%22%34%38%25%8%10%15%23%21%22%
Net Profit +-89-573597133115132340141173231293
EPS in Rs-14.32-9.185.6615.5921.4218.5221.2654.9020.2127.9537.3143.68
Dividend Payout %0%0%9%13%14%16%14%7%19%14%13%17%

Financials of India Glycols

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital313131313131313131313134
Reserves2666877218149321,0031,1381,7611,8702,0202,2252,899
Borrowings +2,2641,2361,0958341,0009991,1371,0471,1121,3481,8921,691
Other Liabilities +5931,6651,6451,7421,8212,0531,8141,7921,8452,2182,0291,900
Total Liabilities3,1543,6203,4923,4213,7844,0864,1194,6314,8585,6176,1766,523
Fixed Assets +1,1462,0292,1112,1562,1732,2282,1932,3182,7173,2053,8294,554
CWIP1621819189137172126243125849837
Investments4282524212627336318335381389
Other Assets +1,8431,3821,2651,1521,4531,6601,7741,7341,6981,9931,8671,543
Total Assets3,1543,6203,4923,4213,7844,0864,1194,6314,8585,6176,1766,523

Financials of India Glycols

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-1711,231302502147343137116326439362769
Cash from Investing Activity +175-78-40-103-128-151-14876-330-503-736-767
Cash from Financing Activity +-4-1,168-263-3993-21611-189-19035423
Net Cash Flow-0-15-1-022-23-04-525-2025
Free Cash Flow-531,1372603739193-11-264-109-103-391-47
CFO/OP-136%705%127%156%37%127%53%51%123%108%73%122%

Financials of India Glycols

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days625757403576575159433530
Inventory Days10912812987124146166148209224209122
Days Payable55120144152143155158137209222175108
Cash Conversion Cycle1156642-251767656260447045
Working Capital Days-110-94-117-78-50-64-79-31-46-63-56-49
ROCE %3%5%9%15%20%14%10%9%8%11%12%12%

Guidance history

How India Glycols's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →10–20%FlatPlanned——
Q4 FY26 call →10–20%FlatPlannedPlanned—
Q4 FY26 call →10–20%FlatPlannedNone planned—

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

91out of 100

Momentum score · price trend

91 out of 100 — Strengthening

Over the past year its share price has done better than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months+57.4%87%
Last 6 months+61.1%92%
Last 3 months+35.4%94%
How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For India Glycols: 0.4 × 87 + 0.4 × 92 + 0.2 × 94 = 91.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 16 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What India Glycols's management said in earlier quarters

Others in Beverages this season

  • Tilaknagar Industries Ltd (Q2 FY27)

    Q2 FY27 Revenue from Operations (Net) was INR 1,035 crore, a 172.8% year-on-year (YoY) increase (Page 8). Key investor presentation takeaways from Tilaknagar In

  • Globus Spirits Ltd (Q2 FY27)

    Q2 FY27 Revenue from Operations: INR 7,624 Mn, up 15% YoY (Page 9, Page 6) . Key investor presentation takeaways from Globus Spirits Ltd's Q2 FY27 investor pres

  • Varun Beverages Ltd (Q2 FY27)

    Q3 CY2026 consolidated sales volume: 354.4 million cases, up 28.7% YoY (Q3 CY2025: 275.3 million cases) . Key investor presentation takeaways from Varun Beverag

  • Allied Blenders (Q3 FY26)

    Post UK FTA**: Opportunity to enter and profitably participate in the value Scotch segment (about 50% of luxury segment volumes), currently untapped. Key…

Compare:vs Varun Beverages Ltdvs United Spirits Ltdvs Radico Khaitan Ltd